Results 31 to 40 of about 6,681 (143)

Dupilumab Treatment in Pemphigus: A Report of Three Cases and Literature Review

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Pemphigus vulgaris (PV) and foliaceus (PF) are rare autoimmune blistering diseases traditionally treated with systemic corticosteroids, immunosuppressants, intravenous immunoglobulins, and rituximab. Nonetheless, a subset of patients remains refractory or has contraindications to these conventional therapies.
José Javier Mateos Rico   +5 more
wiley   +1 more source

Дослідження з підбору компонентів для створення лікарського засобу для лікування себорейного дерматиту шкіри голови

open access: yesAnnals of Mechnikov's Institute, 2023
Introduction. Seborrheic dermatitis is a chronic recurrent skin disease associated with increased secretion of skin sebum, a change in its qualitative composition, and is characterized by localization in areas of accumulation of sebaceous glands - on the
Ilona Konovalenko, Albina Cherkasova
doaj   +1 more source

Refractory Seborrheic Dermatitis of the Head in a Patient with Malignant Lymphoma

open access: yesCase Reports in Dermatology, 2014
Seborrheic dermatitis is an inflammatory eruption that tends to distribute on the sebaceous areas of the body and is rarely described as a paraneoplasia.
Kayo Okada   +5 more
doaj   +1 more source

Barriers to Accurate Diagnosis of Infantile Atopic Dermatitis: Insights From a Survey of Pediatricians

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Accurate diagnosis is essential for timely intervention in atopic dermatitis (AD), yet delays in diagnosis remain common. To better understand current clinical practices regarding infantile AD, a questionnaire survey was conducted among Japanese pediatricians working at medical institutions with 19 or fewer beds.
Kiwako Yamamoto‐Hanada   +6 more
wiley   +1 more source

Postauricular Skin Mycobiome Profiles in Atopic Dermatitis Treated With Dupilumab or Cyclosporine A: A Descriptive Case Series

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Atopic dermatitis (AD) essentially exhibits dysbiosis of skin fungal microbiome, mycobiome, characterized by depletion of Malassezia. The effects of recent systemic therapies for AD on skin mycobiome were not understood enough. We examined changes of skin mycobiome before and after systemic treatments with anti‐IL‐4Rα antibody (dupilumab: DUP)
Yuta Koike   +5 more
wiley   +1 more source

Nutrition, Obesity, and Seborrheic Dermatitis: Systematic Review

open access: yesJMIR Dermatology
BackgroundPathogenesis of seborrheic dermatitis involves lipid secretion by sebaceous glands, Malassezia colonization, and an inflammatory response with skin barrier disruption.
Emily Woolhiser   +5 more
doaj   +1 more source

Chinese herbal medicine for seborrheic dermatitis complicated by allergy to topical agent: A case report

open access: yesJournal of Traditional Chinese Medical Sciences, 2017
Seborrheic dermatitis is a common inflammatory dermatosis. Conventional medical treatments include corticosteroids, calcineurin inhibitors, and other therapeutic modalities.
Mingliang Xiao   +3 more
doaj   +1 more source

Bidirectional Associations Between Seborrheic Dermatitis and Epithelial Barrier Diseases: A Retrospective Cohort Study

open access: yesAllergy, EarlyView.
This study explores the bidirectional associations between SD and EBDs in a cohort of 5,083,689 individuals in a US administrative claims database. Positive bidirectional associations were found between SD and many EBDs of the skin, respiratory, gastrointestinal, and ocular surfaces. Our results support the EBT as a shared driver of EBD pathogenesis at
Sabrina Meng   +6 more
wiley   +1 more source

Comparison the Efficacy of Fluconazole and Terbinafine in Patients with Moderate to Severe Seborrheic Dermatitis

open access: yesDermatology Research and Practice, 2014
Background. Topical agents can be unpleasant due to long-term therapies in patients with moderate to severe seborrheic dermatitis. Systemic antifungal therapy is another alternative in treatment. Aim.
Narges Alizadeh   +5 more
doaj   +1 more source

Pityriasis amiantacea: a study of seven cases [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2016
: Pityriasis amiantacea was first described in 1832. The disease may be secondary to any skin condition that primarily affects the scalp, including seborrheic dermatitis. Its pathogenesis remains uncertain.
Gustavo Moreira Amorim   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy